BioCentury
ARTICLE | Financial News

Addex prices IPO

May 22, 2007 1:27 AM UTC

Neurology and gastrointestinal company Addex (SWX:ADXN) raised CHF137 million ($111.6 million) through the sale of 1.9 million shares at CHF73 in an IPO on the SWX Swiss Exchange and a private placement outside Switzerland. The price was near the top of the company's proposed range of CHF58-CHF75 and values the company at CHF428 million ($348.8 million). Lehman is global coordinator and bookrunner. Piper Jaffray; Bank Vontobel; and Bank am Bellevue are co-lead managers. The stock will begin trading on Tuesday. ...